Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 50 mg/g - ointment - excipient ingredients: propylene glycol; macrogol 1500; macrogol 3350; macrogol 300 - temporary relief of pain associated with minor burns, non-blistered sunburn, insect bites, sore nipples.,anaesthesia of mucous membranes e.g. various anal conditions such as haemorrhoids and fissures.,anaesthetic lubricant during examination and instrumentation e.g. proctoscopy, sigmoidoscopy.,surface anaesthesia of the gums prior to injection, before deep scaling and in conjunction with the fitting of new dentures.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine, quantity: 50 mg/g - ointment - excipient ingredients: propylene glycol; macrogol 3350; macrogol 1500; macrogol 300; purified water - temporary relief of pain associated with minor burns, non-blistered sunburn, insect bites, sore nipples.,anaesthesia of mucous membranes e.g. various anal conditions such as haemorrhoids and fissures.,anaesthetic lubricant during examination and instrumentation e.g. proctoscopy, sigmoidoscopy.,surface anaesthesia of the gums prior to injection, before deep scaling and in conjunction with the fitting of new dentures.

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - lidocaine - ointment - 50 mg/g - lidocaine 5g/100g

Canada - English - Health Canada

aspen pharmacare canada inc. - lidocaine - ointment - 5% - lidocaine 5% - antipruritics and local anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections; dilute hydrochloric acid - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; dilute hydrochloric acid - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; sodium metabisulfite; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - lidocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; water for injections - xylocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques; infiltration, intravenous regional anaesthesia - excluding solutions with adrenaline, peripheral nerve block such as intercostal block, major plexus block such as brachial plexus block, epidural block, subarachnoid block